Short description
Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.
Description
Dxcover is a clinical-stage liquid biopsy firm that is developing diagnostics for the early diagnosis of numerous malignancies, when treatment has a better possibility of having an influence on outcomes. The business was the first to use infrared spectroscopy of circulating pan-omic indicators to detect and identify cancer. The business has generated compelling clinical data on the diagnosis of Stage I and Stage II malignancies with high accuracy.
Dxcover was established in 2016 in Glasgow, Glasgow City by David S Palmer, Holly Butler, and Matthew Baker.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Glasgow, Glasgow City, United Kingdom, Europe
Founded on
January 1, 2016
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Absolutely Noaccess, Nopepepe, No Way, Noaccessforu, Noaccess, Uh Ohhhh, Noaccess, Uh Ohhhh, Noaccessforu, Noaccessforu, Blurry Noaccess, Cannot Access, Noaccess
Sign in for full access
Founders
David S Palmer, Holly Butler, Matthew Baker